US EditionUS FDA approves CT angiography system for visualising cardiac conduction system
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
US FDA approves CT angiography system for visualising cardiac conduction system
Cara Medical has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the CARA system, a computed tomography angiography (CTA)-based platform that provides non-invasive, patient-specific three-dimensional (3D) visualisation of the cardiac conduction system. The CARA system, which received FDA breakthrough device designation last year, enables visualisation of the location of the cardiac conduction system rela…
CARA System Receives FDA 510(k) Clearance
Cara Medical Ltd. recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the CARA System, a computed tomography angiography (CTA)-based platform that provides noninvasive, patient-specific three-dimensional (3D) visualization of the cardiac conduction system. The CARA System, which received FDA Breakthrough Device Designation last year, enables visualization of the location of the cardiac conduction …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
